Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies — NHYP  

Chemotherapy-induced Neuropathy Clinical Trial

Official title: Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

Status Recruiting

Clinical Trial Summary

Chimiotherapy produces neuropathies injuries to 30% to 70% cases. A third of those patients keeps suffering from this side effects disabilities and their quality of life is seriously affected. Hypnosis, as a non-invasive tool without physical side effects, might be used to relieve them. the purpose of this trial based on our own experience, is to demonstrate the value of using hypnosis and self-hypnosis in chimiotherapy- induced chronic neuropathies. The aim will be to sustainably improve the quality of life by expanding self-management of pain and motor function side effect.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Chemotherapy-induced Neuropathy
• Peripheral Nervous System Diseases

• NCT number: NCT03156595
• Study type: Interventional
• Source: University Hospital, Strasbourg, France
• Contact: Anne Laudamy
• Phone: +33 3 88 11 66 88
• Email: anne.laudamy@chru-strasbourg.fr
• Status: Recruiting
• Phase: N/A
• Start date: August 4, 2017
• Completion date: November 4, 2021